Dienstag JL - Search Results

1

Sexual and perinatal transmission of hepatitis C.

Dienstag JL. Dienstag JL. Hepatology. 1997 Sep;26(3 Suppl 1):66S-70S. doi: 10.1002/hep.510260712. Hepatology. 1997. PMID: 9305667 Review.

2

Reply to: "Primed for the spotlight: Transplantation for alcohol-associated liver disease".

Luther J, Dienstag JL. Luther J, et al. Among authors: dienstag jl. J Hepatol. 2018 Jul;69(1):255. doi: 10.1016/j.jhep.2018.03.015. Epub 2018 Apr 9. J Hepatol. 2018. PMID: 29650334 No abstract available.

3

Reply to: "Assessment of the risk of alcohol relapse following liver transplantation for alcoholic hepatitis using a meta-analysis approach".

Luther J, Dienstag JL. Luther J, et al. Among authors: dienstag jl. J Hepatol. 2018 Jun;68(6):1323. doi: 10.1016/j.jhep.2018.02.019. Epub 2018 Mar 2. J Hepatol. 2018. PMID: 29505846 No abstract available.

4

Early liver transplantation for alcoholic hepatitis: Ready for primetime?

Kubiliun M, Patel SJ, Hur C, Dienstag JL, Luther J. Kubiliun M, et al. Among authors: dienstag jl. J Hepatol. 2018 Mar;68(3):380-382. doi: 10.1016/j.jhep.2017.11.027. Epub 2017 Nov 24. J Hepatol. 2018. PMID: 29175244 No abstract available.

5

Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.

Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Lau JY, Dienstag JL, Liang TJ. Reid AE, et al. Among authors: dienstag jl. Am J Gastroenterol. 1999 Jun;94(6):1619-26. doi: 10.1111/j.1572-0241.1999.01153.x. Am J Gastroenterol. 1999. PMID: 10364034

6

Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.

Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi AB. Toth CM, et al. Among authors: dienstag jl. Transplantation. 1998 Nov 15;66(9):1254-8. doi: 10.1097/00007890-199811150-00023. Transplantation. 1998. PMID: 9825826

7

Lamivudine as initial treatment for chronic hepatitis B in the United States.

Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Dienstag JL, et al. N Engl J Med. 1999 Oct 21;341(17):1256-63. doi: 10.1056/NEJM199910213411702. N Engl J Med. 1999. PMID: 10528035 Free article. Clinical Trial.

8

Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus.

Chung RT, Monto A, Dienstag JL, Kaplan LM. Chung RT, et al. Among authors: dienstag jl. J Med Virol. 1999 Aug;58(4):353-8. J Med Virol. 1999. PMID: 10421401

9

Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.

Katkov WN, Watkins E, DeMelia HC, Dienstag JL. Katkov WN, et al. Among authors: dienstag jl. J Viral Hepat. 1994;1(1):79-83. doi: 10.1111/j.1365-2893.1994.tb00065.x. J Viral Hepat. 1994. PMID: 8790563 Clinical Trial.

10

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

Harper SE, Dienstag JL. Harper SE, et al. Among authors: dienstag jl. Hepatology. 1996 Apr;23(4):930-3. doi: 10.1002/hep.510230439. Hepatology. 1996. PMID: 8666352 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results